Clinical Trials Logo

Clinical Trial Summary

Neuromuscular blockade is essential to provide optimal conditions for tracheal intubation and also to facilitate the performance of surgeries involving mainly the abdominal cavity. The introduction of neuromuscular blockers in clinical practice optimized the execution of mechanical ventilation. Since the use of these drugs, increased intercurrences such as prolonged muscle paralysis and respiratory complications have been observed, resulting in unfavorable outcomes with residual neuromuscular blockade and delayed recurrence due to the occurrence of these complications. The present study aims to evaluate the incidence of residual neuromuscular blockade and late recurarization in the post-anesthetic recovery room in patients submitted to videolaparoscopic cholecystectomy.


Clinical Trial Description

This is an observational and prospective study in which patients aged 18-50 years classified as ASA (American Society of Anesthesiologists) I and II, body mass index below 35 and who will undergo cholecystectomy will be included. Patients will be allocated to two groups based on the neuromuscular blocker used by the anesthesiologist who participates in the surgery, ie in group C patients will participate in the administration of cisatracurium and the group R will consist of the patients in whom rocuronium was administered. General anesthesia and assessment of muscle function will be performed by measuring the four-stimulus sequence (SQE) / train of four (TOF) at pre-established times. A residual neuromuscular block is considered to be the patient presenting the value of the four-stimulus sequence of T4 / T1 of less than 0.9. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03831815
Study type Observational [Patient Registry]
Source Federal University of Minas Gerais
Contact
Status Completed
Phase
Start date November 3, 2017
Completion date May 18, 2018

See also
  Status Clinical Trial Phase
Completed NCT03292965 - Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery N/A
Not yet recruiting NCT05053594 - Different Doses of Neostigmine for Reversal of Moderate Neuromuscular Blockade in Children Phase 4
Recruiting NCT05724550 - Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children N/A